While more studies have identified CALD1 as a prognostic biomarker in bladder cancer [20, 30], gastric cancer [31], and colorectal cancer [21, 32], there is limited research on its role in OC, including its potential involvement in platinum-based chemotherapy resistance. Here, CALD1 is linked to gastric cancer.